ASMB - Assembly Biosciences, Inc.
| Previous Close | 12.28 |
| Open | 12.40 |
| Bid | 11.77 x 900 |
| Ask | 14.15 x 800 |
| Day's Range | 12.30 - 12.79 |
| 52 Week Range | 11.49 - 41.00 |
| Volume | 134,770 |
| Avg. Volume | 272,111 |
| Market Cap | 321.14M |
| Beta (3Y Monthly) | 0.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Assembly Biosciences (ASMB) Reports Q2 Loss, Lags Revenue Estimates
Assembly Biosciences (ASMB) delivered earnings and revenue surprises of 34.55% and -20.97%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Does The Assembly Biosciences, Inc. (NASDAQ:ASMB) Share Price Tend To Follow The Market?
If you own shares in Assembly Biosciences, Inc. (NASDAQ:ASMB) then it's worth thinking about how it contributes to the...
- Insider Monkey
Here’s What Hedge Funds Think About Assembly Biosciences Inc (ASMB)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very smart and skilled investors. Of course, they may also make wrong bets in some instances, but no one knows what the […]
- Simply Wall St.
Read This Before Selling Assembly Biosciences, Inc. (NASDAQ:ASMB) Shares
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
- Zacks
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates
Assembly Biosciences (ASMB) delivered earnings and revenue surprises of 1.87% and 1.89%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press
Assembly Biosciences: 1Q Earnings Snapshot
On a per-share basis, the Carmel, Indiana-based company said it had a loss of $1.05. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
- Benzinga
The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 2) Alcon AG (NYSE: ALC ) Dr.Reddy's Laboratories Ltd (NYSE: ...
- Zacks
Analysts Estimate Assembly Biosciences (ASMB) to Report a Decline in Earnings: What to Look Out for
Assembly Biosciences (ASMB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Motley Fool
Here's Why Assembly Biosciences Is Slipping Today
Mid-stage clinical trial results weren't what some investors were looking for.
- Motley Fool
4 Biotech Stocks With Major Catalysts in April
April's about to shower biopharma investors with important updates that could move these stocks.
- Simply Wall St.
If You Had Bought Assembly Biosciences Stock Three Years Ago, You Could Pocket A 261% Gain Today
It hasn't been the best quarter for Assembly Biosciences, Inc. (NASDAQ:ASMB) shareholders, since the share price has fallen 19% in that time. But that doesn't undermine the rather lovely longer-termRead More...
- Zacks
Generic-Drugs Outlook: Price Erosion to Hurt Near-Term Prospects
Generic-Drugs Outlook: Price Erosion to Hurt Near-Term Prospects
- Zacks
Mylan (MYL) Jumps: Stock Rises 7.1%
Mylan (MYL) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
- Simply Wall St.
Assembly Biosciences, Inc. (NASDAQ:ASMB) Insiders Increased Their Holdings
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be remiss not to mention that insider sales have Read More...
- Insider Monkey
Here is What Hedge Funds Think About Assembly Biosciences Inc (ASMB)
Concerns over rising interest rates and expected further rate increases have hit several stocks hard since the end of the third quarter. NASDAQ and Russell 2000 indices are already in correction territory. More importantly, Russell 2000 ETF (IWM) underperformed the larger S&P 500 ETF (SPY) by about 4 percentage points in the first half of […]
- Zacks
Amphastar Pharmaceuticals (AMPH) Catches Eye: Stock Jumps 6.7%
Amphastar Pharmaceuticals (AMPH) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
- Simply Wall St.
Should You Worry About Assembly Biosciences Inc’s (NASDAQ:ASMB) CEO Pay?
Derek Small became the CEO of Assembly Biosciences Inc (NASDAQ:ASMB) in 2015. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we’ll consider growth that Read More...
- Zacks
Assembly Biosciences (ASMB) Reports Q3 Loss, Tops Revenue Estimates
Assembly Biosciences (ASMB) delivered earnings and revenue surprises of 14.71% and 33.40%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press
Assembly Biosciences: 3Q Earnings Snapshot
On a per-share basis, the Carmel, Indiana-based company said it had a loss of 87 cents. The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...
- Benzinga
Recent Assembly Biosciences Weakness Provides Attractive Entry Point, B Riley FBR Says In Upgrade
Assembly Biosciences Inc (NASDAQ: ASMB ) shares have shed over one-fourth of their value since late September, creating an opportunity to buy the dip, B. Riley FBR said Monday. The Analyst Analyst Madhu ...
- Simply Wall St.
Shareholders Should Check The Ownership Structure Of Assembly Biosciences Inc (NASDAQ:ASMB)
Every investor in Assembly Biosciences Inc (NASDAQ:ASMB) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often Read More...
